| Medical and Health Sciences | 2021-2025 | 633 | GB 60 | 99.86 |
| Health Information Management | Lifetime | 16 | GB 2 | 99.79 |
| General Health Professions | Lifetime | 505 | GB 82 | 99.42 |
| Epidemiology | Lifetime | 972 | GB 89 | 98.69 |
| Organizational Behavior and Human Resource Management | Lifetime | 689 | GB 87 | 97.95 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 929 | GB 102 | 96.37 |
| Nephrology | Lifetime | 693 | GB 39 | 90.63 |
| Epidemiology | 2021-2025 | 180 | GB 18 | 98.79 |
| Infectious Diseases | 2021-2025 | 365 | GB 35 | 92.92 |
| Health | 2021-2025 | 280 | GB 43 | 91.97 |
| General Health Professions | 2021-2025 | 968 | GB 128 | 91.84 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 376 | GB 41 | 90.14 |
| COVID-19 and healthcare impacts | Lifetime | 59 | GB 14 | 98.54 |
| Electronic Health Records Systems | Lifetime | 24 | GB 4 | 99.21 |
| Healthcare Systems and Technology | Lifetime | 32 | GB 10 | 99.15 |
| Chronic Disease Management Strategies | Lifetime | 95 | GB 20 | 98.99 |
| Medical Coding and Health Information | Lifetime | 11 | GB 3 | 98.95 |
| COVID-19 Clinical Research Studies | Lifetime | 367 | GB 40 | 98.45 |
| Clinical practice guidelines implementation | Lifetime | 83 | GB 19 | 98.71 |
| Primary Care and Health Outcomes | Lifetime | 146 | GB 28 | 98.88 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 805 | GB 57 | 97.51 |
| Diabetes Management and Education | Lifetime | 199 | GB 29 | 97.76 |
| Influenza Virus Research Studies | Lifetime | 561 | GB 51 | 97.56 |
| Data-Driven Disease Surveillance | Lifetime | 132 | GB 14 | 96.61 |
| Biomedical Text Mining and Ontologies | Lifetime | 255 | GB 27 | 96.60 |
| Telemedicine and Telehealth Implementation | Lifetime | 189 | GB 26 | 95.82 |
| Vaccine Coverage and Hesitancy | Lifetime | 586 | GB 53 | 96.41 |
| Diabetes Treatment and Management | Lifetime | 914 | GB 95 | 96.98 |
| Machine Learning in Healthcare | Lifetime | 171 | GB 16 | 95.03 |
| Ethics in Clinical Research | Lifetime | 323 | GB 43 | 94.92 |
| Chronic Kidney Disease and Diabetes | Lifetime | 716 | GB 33 | 96.29 |
| Artificial Intelligence in Healthcare | Lifetime | 359 | GB 16 | 92.84 |
| Healthcare Quality and Management | Lifetime | 202 | GB 57 | 94.14 |
| Mobile Health and mHealth Applications | Lifetime | 698 | GB 68 | 94.53 |
| Delphi Technique in Research | Lifetime | 380 | GB 93 | 92.81 |
| Data Quality and Management | Lifetime | 442 | GB 31 | 93.68 |
| Health Sciences Research and Education | Lifetime | 608 | GB 83 | 91.61 |
| Healthcare cost, quality, practices | Lifetime | 852 | GB 118 | 91.55 |
| Nursing Roles and Practices | Lifetime | 492 | GB 104 | 89.57 |
| Health Literacy and Information Accessibility | Lifetime | 889 | GB 66 | 88.62 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 977 | GB 91 | 79.67 |
| Healthcare Systems and Challenges | Lifetime | 796 | GB 331 | 64.41 |
| Influenza Virus Research Studies | 2021-2025 | 76 | GB 8 | 97.32 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 183 | GB 17 | 96.86 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 681 | GB 61 | 97.32 |
| COVID-19 Clinical Research Studies | 2021-2025 | 908 | GB 101 | 96.32 |
| COVID-19 and healthcare impacts | 2021-2025 | 332 | GB 77 | 94.42 |
| Respiratory viral infections research | 2021-2025 | 217 | GB 21 | 96.10 |
| Pneumonia and Respiratory Infections | 2021-2025 | 369 | GB 44 | 93.09 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 180 | GB 19 | 83.32 |
| Hair Growth and Disorders | 2021-2025 | 471 | GB 15 | 73.49 |
| Clinical practice guidelines implementation | 2021-2025 | 937 | GB 129 | 65.66 |
| Data-Driven Disease Surveillance | 2021-2025 | 610 | GB 54 | 66.65 |
| Intramuscular injections and effects | 2021-2025 | 223 | GB 13 | 51.57 |
| Healthcare Systems and Challenges | 2021-2025 | 342 | GB 148 | 35.91 |
